+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Catheters Market by Product: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4828896
  • Report
  • Region: Global
  • 188 pages
  • Allied Analytics LLP
1 of 4
Catheters Market Overview:

The global catheters market was valued at $10,703 million in 2017 and is estimated to reach $19,976 million by 2025, registering a CAGR of 8.0 % from 2018 to 2025.

Catheters are the medical devices that are made up of medical grade material and are used for both diagnosis as well as treatment purposes. These are usually made of plastic, silicon rubber, polyvinyl chloride (PVC), and nylon, and can easily be inserted in the patient’s body. Catheters primarily allow drainage, administration of fluids in the patient’s body and are used to perform numerous other tasks depending on the type of catheter including cardiovascular, neurovascular, urological, and others.

High prevalence of cardiovascular diseases accompanied with the development of innovative cardiovascular catheters is the major factor that drives the market growth. Increase in prevalence of urological diseases such as urinary bladder cancer and kidney failure, has significantly fueled the demand for urological catheters. Also, novel products such as external male catheters, have proved to be a lucrative addition to the overall catheters and variants product lines for the catheters manufacturing companies. The increase in patient pool for ischemic and hemorrhagic stroke thereby increased the demand for minimally invasive neurovascular surgeries, thus making way for opportunities for the neurovascular catheters micro catheters and guiding catheters. Increase in cardiovascular diseases and growth in demand for minimal invasive surgeries drive the global catheters market. Rise in incidence of diabetes, cardiovascular diseases, urinary bladder, and kidney failures also fuel the market growth.

The catheters market is segmented based on product and region. Based on product, the market is divided into cardiovascular catheters, neurovascular catheters, urological catheters, intravenous catheters, specialty catheters. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits of Catheters Market:

The study provides an in-depth analysis of the global catheters market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the catheters market.

Key players and their strategies are provided to understand the competitive outlook of the industry.

Catheters Market Key Segments:

By Product

Cardiovascular Catheters
Electrophysiology Catheters
PTCA Balloons Catheters
IVUS Catheters
PTA Balloons Catheters
Others
Neurovascular Catheters
Urological Catheters
Dialysis Catheter
Hemodialysis Catheters
Peritoneal Catheters
Dialysis Catheter
Foley Catheters
Intermittent Catheters
External Catheters
Intravenous Catheters
Central Venous Catheters
Peripheral Venous Catheters
Integrated Catheters
Short Catheters
Specialty Catheters
Wound/Surgical Drain
Oximetry
Thermodilution
IUI Catheters

By Region

North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
France
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Rest of LAMEA

Key Market Players

Abbott Laboratories
Becton Dickinson And Company
Boston Scientific Corporation
Stryker Corporation
B. Braun Melsungen AG
Teleflex Incorporated
Johnson & Johnson
Medtronic, Inc
Edwards Lifesciences Corp
Cook Medical

The other players in the value chain include (profiles not included in the report)

Hollister Incorporated
Manfred Sauer
Smiths Medical
Wellspect Healthcare
Cure Medical
Convatech Inc
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.3. Patent Analysis
3.3.1. Patent analysis by geography (2016-2018)
3.3.2. Patent analysis by applicants (2015-2016)
3.4. Clinical Trials For Catheters
3.5. Porters five forces analysis
3.6. Value chain analysis
3.6.1. Primary activities
3.6.2. Support activities
3.7. Market share analysis, 2017
3.8. Government regulations and reimbursements
3.8.1. Catheter regulation in the U.S. and Europe
3.8.2. Reimbursements
3.8.2.1. U.S.
3.8.3. Europe
3.9. Market dynamics
3.9.1. Drivers
3.9.1.1. Growing demand for minimally invasive procedures
3.9.1.2. Increase in adoption of catheters
3.9.1.3. Surge in geriatric population
3.9.2. Restraints
3.9.2.1.Rise in Catheter-associated Urinary Tract Infections (CAUTI)
3.9.2.2.Inadequate quality assurance
3.9.3. Opportunities
3.9.3.1. Opportunities in emerging economies

CHAPTER 4: CATHETERS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Cardiovascular Catheters
4.2.1. Key market trends and opportunity
4.2.2. Market size and forecast
4.2.3. Electrophysiology Catheters
4.2.3.1. Market size and forecast
4.2.4. PTCA Balloons Catheters
4.2.4.1. Market size and forecast
4.2.5. Intravascular ultrasound (IVUS) Catheters
4.2.5.1. Market size and forecast
4.2.6. Percutaneous transluminal angioplasty (PTA) balloon Catheters
4.2.6.1. Market size and forecast
4.2.7. Others
4.2.7.1. Market size and forecast
4.2.7.1.1. Guiding Catheters
4.2.7.1.2. Angiography catheters
4.2.7.1.3. Pulmonary artery catheters
4.3. Neurovascular Catheters
4.3.1. Key Market Trends and Opportunity
4.3.2. Market size and forecast
4.4. Urological Catheters
4.4.1. Key Market Trends and Opportunities
4.4.2. Market size and forecast
4.4.3. Dialysis catheter
4.4.3.1. Market size and forecast
4.4.3.2. Hemodialysis catheter
4.4.3.2.1. Market size and forecast
4.4.3.3. Peritoneal catheter
4.4.3.3.1. Market size and forecast
4.4.4. Urinary catheter
4.4.4.1. Market size and forecast
4.4.4.2. Foley Catheters
4.4.4.2.1. Market size and forecast
4.4.4.3. Intermittent Catheters
4.4.4.3.1. Market size and forecast
4.4.4.4. External Catheters
4.4.4.4.1. Market size and forecast
4.5. Intravenous Catheters
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast
4.5.3. Central venous catheters
4.5.3.1. Market size and forecast
4.5.4. Peripheral venous catheters
4.5.4.1. Market size and forecast
4.5.4.2. Integrated Catheters
4.5.4.2.1. Market size and forecast
4.5.4.3. Short Catheter
4.5.4.3.1. Market size and forecast
4.6. Specialty Catheters
4.6.1. Key market trends and opportunity
4.6.2. Market size and forecast
4.6.3. Wound / Surgical drain
4.6.3.1. Market size and forecast
4.6.4. Oximetry
4.6.4.1. Market size and forecast
4.6.5. Thermodilution
4.6.5.1. Market size and forecast
4.6.6. IUI catheters
4.6.6.1. Market size and forecast

CHAPTER 5: CATHETERS MARKET, BY REGION
5.1. Overview
5.1.1. Market size and forecast
5.2. North America
5.2.1. Key trends and opportunities
5.2.2. North America market size & forecast, by product
5.2.3. North America market size & forecast, by country
5.2.3.1. U.S. market size & forecast
5.2.3.2. Canada market size & forecast
5.2.3.3. Mexico market size & forecast
5.3. Europe
5.3.1. Key trends and opportunities
5.3.2. Europe market size & forecast, by product
5.3.3. Europe market size & forecast for catheters market, by country
5.3.3.1. Germany market size & forecast
5.3.3.2. France market size & forecast
5.3.3.3. UK market size & forecast
5.3.3.4. Italy market size & forecast
5.3.3.5. Russia market size & forecast
5.3.3.6. Rest of Europe market size & forecast
5.4. Asia-Pacific
5.4.1. Key trends and opportunities
5.4.2. Asia-Pacific market size & forecast, by country
5.4.3. Asia-Pacific market size & forecast, by product
5.4.3.1. Australia market size & forecast
5.4.3.2. China market size & forecast
5.4.3.3. India market size & forecast
5.4.3.4. Japan market size & forecast
5.4.3.5. Rest of Asia-Pacific market size & forecast
5.5. LAMEA
5.5.1. Key trends and opportunities
5.5.2. LAMEA market size & forecast, by country
5.5.3. LAMEA market size & forecast, by product
5.5.3.1. Brazil market size & forecast
5.5.3.2. Saudi Arabia market size & forecast
5.5.3.3. Turkey market size & forecast
5.5.3.4. Rest of LAMEA market size & forecast

CHAPTER 6: COMPANY PROFILES
6.1. Abbott Laboratories
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments
6.2. B. Braun Melsungen AG
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.3. Becton, Dickinson and Company
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.3.5. Business performance
6.3.6. Key strategic moves and developments
6.4. Boston Scientific Corporation
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Business performance
6.4.1. Key strategic moves and developments
6.5. Johnson & Johnson
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.5.6. Key strategic moves and developments
6.6. Medtronic Plc.
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segment
6.6.4. Product portfolio
6.6.5. Business performance
6.6.6. Key strategic moves and developments
6.7. Edwards Lifesciences Corporation
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance
6.8. Teleflex Incorporated
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance
6.9. Cook Medical Inc.
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.10. Stryker Corporation
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Business performance
6.10.6. Key strategic moves and developments

*Full List of Tables and Figures Available on Enquiry.

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to this report titled Catheters Market by Product: Global Opportunity Analysis and Industry Forecast, 2018-2025, the global catheters market was valued at $10,703 million in 2017 and is projected to reach $19,976 million by 2025, growing at a CAGR of 8.0% from 2018 to 2025. North America was the highest revenue contributor in 2017 and is expected to remain the same throughout the forecast period.

Catheter is a thin tube made from medical grade materials that serve a comprehensive range of functions. They are medical devices that can easily be inserted in the patients body for the treatment of various diseases or even perform a surgical procedure. For instance, cardiovascular catheters are used to draw blood and provide treatments, including intravenous fluids, drugs, or blood transfusions. The scope of applications of catheters has widened, as they are used to treat various neurological, cardiovascular, urological, and other disorders, with the help of improved clinical practices and advanced technologies.

The catheter devices have gained significant traction in the recent years owing to significant rise in cardiovascular & urological diseases across the globe. Rise in demand for minimally invasive surgeries for the diagnosis and treatment of cardiovascular, neurological, and other diseases drive the growth of the catheters market. Further, catheter-based surgeries are minimally invasive and require shorter recovery times. Surgeries done with the help of catheters are less invasive and lead to faster recovery.

Based on product, the cardiovascular segment accounted for the majority of catheter market share of the global market in 2017. This is attributed to the significant increase in cardiovascular diseases across the globe and surge in use of these catheters for the treatment of the same. However, urological catheter segment is anticipated to exhibit prominent growth rate during the forecast period owing to the significant rise in geriatric population and use of these catheters to deal with inconsistency.

Key Findings of the Catheters market:

Based on product, the cardiovascular catheters segment accounted for nearly half share of the catheters industry in 2017.

The urological catheters segment is anticipated to grow at the highest growth rate throughout the forecast period.

Based on region, North America accounted for a major share of the global catheters market in 2017.

LAMEA is anticipated to grow at the highest rate in the catheters market during the analysis period, followed by Asia-Pacific.

North America was the leading revenue contributor to the global market in 2017, owing to highly advanced healthcare infrastructure and new product launches by the key players. LAMEA is expected to witness the highest growth rate throughout the forecast period, owing to the increase in awareness among healthcare professional regarding use of catheters for the treatment and diagnosis of various disease including urological, kidney failures, and others.

The report provides a comprehensive analysis of the leading companies operating in the global market such as Abbott Laboratories, Becton Dickinson And Company, Boston Scientific Corporation, Stryker Corporation, Cook Medical, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson, Medtronic, Inc., Edwards Lifesciences Corp., and Vascular Solutions, Inc. The other players in the value chain (not included in the report) include Other players in the value chain include Hollister Incorporated, Manfred Sauer, Smiths Medical, Wellspect Healthcare, Cure Medical, and Convatech Inc.
Note: Product cover images may vary from those shown
5 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll